MetaCap

BridgeBio Pharma Statistics

NASDAQ: BBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

76.03-2.15 (-2.75%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BridgeBio Pharma by the numbers

BridgeBio Pharma has a market capitalization of $14.81 billion based on 194.80M shares outstanding. With trailing EPS of $-3.03, BridgeBio Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% above its 50-day average and 4.5% above its 200-day average.

Average daily trading volume is 2.67M shares, or about $202.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BBIO valuation vs. peer median

BBIO compared with the median of 8 peer companies
MetricBBIOPeer medianDifference
Market cap$14.81B$12.64B+17%
Avg. volume2.67M1.97M+35%

Peer median across 8 companies: JAZZ, ASND, ELAN, RDY, BMRN, ALNY, TGTX, SYRE.

Valuation

Market cap
$14.81B
Price / sales (latest FY)
29.50
EPS (TTM)
$-3.03

Price and trading

Previous close
78.18
Open
77.85
Day range
75.46 – 78.22
52-week range
62.50 – 93.42
52-week change
+11.63%
Beta
—
Volume
1.48M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
14.81B
Forward Pe
-278.15
Eps
-3.03
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
93.42
Week52 Low
62.50
Avg Volume
2.67M
Shares Outstanding
194.80M
Ma50
70.30
Ma200
72.76
Earnings Date
Oct 29, 2026
Pct From52w High
-18.61%
Pct From52w Low
21.65%

Related